The Joint Corp.

NasdaqCM:JYNT Voorraadrapport

Marktkapitalisatie: US$179.2m

Joint Toekomstige groei

Future criteriumcontroles 3/6

De omzet van Joint zal naar verwachting dalen met 12.9% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 136% per jaar. De winst per aandeel zal naar verwachting groeien met 137.8% per jaar.

Belangrijke informatie

136.0%

Groei van de winst

137.8%

Groei van de winst per aandeel

Healthcare winstgroei19.9%
Inkomstengroei-12.9%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt15 Oct 2024

Recente toekomstige groei-updates

Recent updates

The Joint Corp.'s (NASDAQ:JYNT) Price Is Out Of Tune With Revenues

Sep 14
The Joint Corp.'s (NASDAQ:JYNT) Price Is Out Of Tune With Revenues

The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Aug 05
The Joint Corp. (NASDAQ:JYNT) Shares Could Be 22% Above Their Intrinsic Value Estimate

Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Jul 17
Investors Could Be Concerned With Joint's (NASDAQ:JYNT) Returns On Capital

Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

May 04
Optimistic Investors Push The Joint Corp. (NASDAQ:JYNT) Shares Up 26% But Growth Is Lacking

The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

Mar 10
The Joint Corp.'s (NASDAQ:JYNT) Share Price Not Quite Adding Up

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Feb 12
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Jun 17
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

Jan 04
Joint's (NASDAQ:JYNT) Returns On Capital Are Heading Higher

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Oct 27
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

The Joint Corp. Can Relieve You From High Inflation Pain

Oct 17

The Joint Corp.: Weakening Bottom-Line Fundamentals Unsupportive In Current Landscape

Aug 05

These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Jul 22
These 4 Measures Indicate That Joint (NASDAQ:JYNT) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Jun 29
Returns Are Gaining Momentum At Joint (NASDAQ:JYNT)

Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Jun 14
Is There Now An Opportunity In The Joint Corp. (NASDAQ:JYNT)?

Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Mar 03
Joint's (NASDAQ:JYNT) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Feb 23
Should You Be Adding Joint (NASDAQ:JYNT) To Your Watchlist Today?

Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Feb 08
Does Joint (NASDAQ:JYNT) Have A Healthy Balance Sheet?

Joint Corp.: Solid Q4 Results From This Small-Cap Growth Story

Jan 30

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Jan 24
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?

Jan 08
What Does The Joint Corp.'s (NASDAQ:JYNT) Share Price Indicate?

Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?

Nov 23
Do Joint's (NASDAQ:JYNT) Earnings Warrant Your Attention?

Is Joint (NASDAQ:JYNT) A Risky Investment?

Nov 08
Is Joint (NASDAQ:JYNT) A Risky Investment?

Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Oct 21
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue

Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?

Oct 05
Is The Joint Corp. (NASDAQ:JYNT) Potentially Undervalued?

The Joint Corporation: Time To Take Some Profits

Aug 10

Winst- en omzetgroeiprognoses

NasdaqCM:JYNT - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20268399101
12/31/2025102610115
12/31/2024116-3565
6/30/2024120-1469N/A
3/31/2024119-11711N/A
12/31/2023118-101015N/A
9/30/202311521116N/A
6/30/202311241117N/A
3/31/20231073814N/A
12/31/2022101128N/A
9/30/202295004N/A
6/30/2022892-23N/A
3/31/2022855612N/A
12/31/2021808714N/A
9/30/20217618817N/A
6/30/202170171017N/A
3/31/20216315712N/A
12/31/20205913711N/A
9/30/2020564610N/A
6/30/202053348N/A
3/31/202051349N/A
12/31/201948338N/A
9/30/201945258N/A
6/30/201941248N/A
3/31/201939146N/A
12/31/201837045N/A
9/30/201834-123N/A
6/30/201831-111N/A
3/31/201828-2N/A1N/A
12/31/201725-3N/A0N/A
9/30/201724-9N/A-2N/A
6/30/201723-11N/A-4N/A
3/31/201722-13N/A-6N/A
12/31/201621-15N/A-11N/A
9/30/201619-13N/A-13N/A
6/30/201617-12N/A-12N/A
3/31/201616-10N/A-11N/A
12/31/201514-9N/A-7N/A
9/30/201512-8N/A-4N/A
6/30/201510-7N/A-3N/A
3/31/20158-5N/A-2N/A
12/31/20147-3N/A0N/A
9/30/201470N/A0N/A
6/30/201460N/A0N/A
3/31/201460N/A0N/A
12/31/201360N/A0N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat JYNT de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 2.6% ).

Winst versus markt: Er wordt verwacht dat JYNT de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat JYNT binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van JYNT zal naar verwachting de komende 3 jaar dalen ( -12.9% per jaar).

Hoge groei-inkomsten: De omzet van JYNT zal naar verwachting de komende 3 jaar dalen ( -12.9% per jaar).


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van JYNT naar verwachting over 3 jaar hoog zal zijn


Ontdek groeibedrijven